We then separately transferred an equivalent number (50,000) of CD4+ T cells isolated from M002-treated tumor or the saline-treated counterpart into Tcrα−/− recipients that were then implanted with GSC005 cells at day 3 post-transfer (Supplementary Fig. 6a). The gene discussed is CD4; the disease is neoplasm.